X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (111726) 111726
Newsletter (2374) 2374
Newspaper Article (701) 701
Book Chapter (671) 671
Magazine Article (406) 406
Dissertation (236) 236
Conference Proceeding (108) 108
Book / eBook (88) 88
Web Resource (76) 76
Publication (52) 52
Reference (34) 34
Government Document (31) 31
Book Review (22) 22
Trade Publication Article (9) 9
Paper (6) 6
Journal / eJournal (4) 4
Report (2) 2
Streaming Video (2) 2
Microfilm (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (74137) 74137
male (52226) 52226
hyperplasia (44944) 44944
female (36073) 36073
middle aged (27140) 27140
aged (22392) 22392
adult (21299) 21299
animals (20863) 20863
urology & nephrology (10399) 10399
benign prostatic hyperplasia (9125) 9125
pathology (8041) 8041
surgery (7589) 7589
aged, 80 and over (7486) 7486
rats (7452) 7452
cancer (7286) 7286
adolescent (7218) 7218
diagnosis, differential (6991) 6991
mice (6805) 6805
oncology (6671) 6671
prostate (6390) 6390
hyperplasia - pathology (6219) 6219
expression (6117) 6117
child (6022) 6022
immunohistochemistry (5835) 5835
endocrinology & metabolism (5717) 5717
diagnosis (5659) 5659
prostatic hyperplasia - surgery (5637) 5637
hypertrophy (5530) 5530
research (5443) 5443
treatment outcome (5137) 5137
retrospective studies (4736) 4736
biopsy (4596) 4596
time factors (4443) 4443
analysis (4198) 4198
prostatic hyperplasia - pathology (4190) 4190
follow-up studies (4133) 4133
risk factors (4041) 4041
prostatic hyperplasia - complications (4021) 4021
carcinoma (3954) 3954
tumors (3712) 3712
prostate cancer (3703) 3703
prostatic hyperplasia - drug therapy (3700) 3700
child, preschool (3492) 3492
inflammation (3316) 3316
disease (3296) 3296
intimal hyperplasia (3291) 3291
prostate - pathology (3258) 3258
cell biology (3204) 3204
men (3187) 3187
care and treatment (3159) 3159
medicine & public health (3137) 3137
radiology, nuclear medicine & medical imaging (3136) 3136
medicine, general & internal (3097) 3097
prostatic hyperplasia (3030) 3030
prostatic neoplasms - pathology (3018) 3018
prospective studies (2976) 2976
infant (2883) 2883
prostatic hyperplasia - diagnosis (2847) 2847
prognosis (2810) 2810
disease models, animal (2774) 2774
peripheral vascular disease (2757) 2757
health aspects (2756) 2756
ultrasonography (2747) 2747
proliferation (2709) 2709
cardiac & cardiovascular systems (2667) 2667
urology (2647) 2647
prostatectomy (2643) 2643
pregnancy (2621) 2621
abridged index medicus (2527) 2527
obstetrics & gynecology (2525) 2525
cells (2509) 2509
lesions (2494) 2494
apoptosis (2486) 2486
mutation (2475) 2475
biochemistry & molecular biology (2463) 2463
gene expression (2419) 2419
pharmacology & pharmacy (2410) 2410
pediatrics (2403) 2403
tunica intima - pathology (2392) 2392
infant, newborn (2369) 2369
cell proliferation (2361) 2361
cells, cultured (2344) 2344
liver - pathology (2336) 2336
gastroenterology & hepatology (2303) 2303
management (2289) 2289
risk (2279) 2279
medicine, research & experimental (2270) 2270
growth (2236) 2236
prostatic hyperplasia - metabolism (2230) 2230
congenital adrenal-hyperplasia (2202) 2202
congenital adrenal hyperplasia (2199) 2199
restenosis (2196) 2196
magnetic resonance imaging (2181) 2181
prostatic hyperplasia - therapy (2135) 2135
research article (2129) 2129
therapy (2122) 2122
adenocarcinoma - pathology (2118) 2118
prevalence (2117) 2117
sensitivity and specificity (2108) 2108
liver (2103) 2103
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (60) 60
Online Resources - Online (17) 17
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Scarborough Hospital - Online (2) 2
UTL at Downsview - May be requested (2) 2
Baycrest Hospital - Wellness Library (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Media Commons - Audio Visual (1) 1
Media Commons - Microtexts (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (100462) 100462
German (3969) 3969
French (3283) 3283
Japanese (2666) 2666
Russian (2240) 2240
Spanish (1901) 1901
Italian (1466) 1466
Chinese (1361) 1361
Portuguese (672) 672
Polish (511) 511
Korean (383) 383
Czech (258) 258
Hungarian (198) 198
Turkish (169) 169
Dutch (155) 155
Danish (123) 123
Bulgarian (107) 107
Romanian (107) 107
Swedish (92) 92
Norwegian (74) 74
Croatian (72) 72
Slovak (52) 52
Ukrainian (45) 45
Serbian (43) 43
Hebrew (41) 41
Finnish (29) 29
Persian (23) 23
Lithuanian (15) 15
Greek (14) 14
Bosnian (8) 8
Slovenian (5) 5
Arabic (4) 4
Thai (4) 4
Afrikaans (3) 3
Icelandic (3) 3
Indonesian (2) 2
Azerbaijani (1) 1
Breton (1) 1
Estonian (1) 1
Latin (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, p. e59449
Journal Article
The journal of clinical endocrinology and metabolism, ISSN 1945-7197, 2018, Volume 103, Issue 11, pp. 4043 - 4088
Journal Article
European urology, ISSN 0302-2838, 2011, Volume 60, Issue 4, pp. 809 - 825
Abstract Context This review focuses on the relationship among sexual dysfunction (SD), lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia... 
Urology | PDE5 | PDE5-i | IIEF | IPSS | Benign prostatic hyperplasia | LUTS | BPH | Prostate | EjD | Age | NITRIC-OXIDE SYNTHASE | SELECTIVE ALPHA-1A-BLOCKER | HOLMIUM LASER ENUCLEATION | RHOA/RHO-KINASE | MEDICAL THERAPY | DOUBLE-BLIND | UROLOGY & NEPHROLOGY | QUALITY-OF-LIFE | TRANSURETHRAL RESECTION | ERECTILE DYSFUNCTION | AGING MEN | ED | Meta-Analysis as Topic | Prevalence | Sexual Dysfunction, Physiological - physiopathology | Humans | Sexual Dysfunction, Physiological - drug therapy | Male | Lower Urinary Tract Symptoms - epidemiology | Prostatic Hyperplasia - complications | Prostatic Hyperplasia - epidemiology | Lower Urinary Tract Symptoms - drug therapy | rho-Associated Kinases - metabolism | Adrenergic alpha-1 Receptor Antagonists - therapeutic use | Lower Urinary Tract Symptoms - etiology | Lower Urinary Tract Symptoms - surgery | Phosphodiesterase 5 Inhibitors - therapeutic use | Drug Therapy, Combination | Prostatic Hyperplasia - drug therapy | Atherosclerosis - drug therapy | Lower Urinary Tract Symptoms - physiopathology | Clinical Trials as Topic | Prostatic Hyperplasia - surgery | Sexual Dysfunction, Physiological - etiology | Sexual Dysfunction, Physiological - surgery | Cyclic GMP - metabolism | Sexual Dysfunction, Physiological - epidemiology | Prostatic Hyperplasia - physiopathology | Nitric Oxide - metabolism | Medical colleges | Sexual disorders | Analysis | Hypertrophy
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2010, Volume 362, Issue 13, pp. 1192 - 1202
Dutasteride, an inhibitor of 5α-reductase in the prostate, was tested in a large, randomized trial to determine its ability to prevent prostate cancer. Over... 
MODELING APPROACH | MEDICINE, GENERAL & INTERNAL | DESIGN | THERAPY | 5-ALPHA-REDUCTASE INHIBITOR DUTASTERIDE | SENSITIVITY | FINASTERIDE | GRADE | HYPERPLASIA | PROGRESSION | PREVENTION TRIAL | Enzyme Inhibitors - adverse effects | Prostatic Neoplasms - pathology | Prostatic Hyperplasia - pathology | Double-Blind Method | Erectile Dysfunction - chemically induced | Humans | Middle Aged | 5-alpha Reductase Inhibitors | Male | Risk | Treatment Outcome | Azasteroids - therapeutic use | Enzyme Inhibitors - therapeutic use | Prostate-Specific Antigen - blood | Azasteroids - adverse effects | Prostate - pathology | Prostatic Neoplasms - genetics | Biopsy | Protein Isoforms | Dutasteride | Aged | Prostatic Neoplasms - prevention & control | Prostatic Hyperplasia - drug therapy | Heart Failure - chemically induced | Usage | Diagnosis | Health aspects | Prostate cancer | Risk factors | Patient safety | Age | Men | Tumors | Prostate-Specific Antigen | Erectile Dysfunction | Enzyme Inhibitors | Testosterone 5-alpha-Reductase | Prostatic Hyperplasia | Life Sciences | Prostatic Neoplasms | Azasteroids | Heart Failure | Prostate | Cancer | pathology | genetics | Urologi och njurmedicin | chemically induced | drug therapy | prevention & control | blood | adverse effects | Cancer and Oncology | Urology and Nephrology | therapeutic use | Cancer och onkologi
Journal Article